Skip to main content
The Journal of Pharmacology and Experimental Therapeutics logoLink to The Journal of Pharmacology and Experimental Therapeutics
. 2025 Apr 29;392(4):103567. doi: 10.1016/j.jpet.2025.103567

Retraction notice to “The Procognitive and Synaptogenic Effects of Angiotensin IV–Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System” [J Pharmacol Exp Ther 351 (2014) 390-402]

Caroline C Benoist 1, Leen H Kawas 1,2, Mingyan Zhu 1, Katherine A Tyson 1, Lori Stillmaker 1, Suzanne M Appleyard 1, John W Wright 1,2,3, Gary A Wayman 1,∗, Joseph W Harding 1,2,3,∗
PMCID: PMC13095468  PMID: 40312093

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal).

This article has been retracted at the request of the Editor.

Following an investigation by Washington State University, Figures 1B, 2A/C, and data in the subsequent erratum submission for the article have been found to contain falsified and/or fabricated data and Leen H. Kawas and Joseph W. Harding were found to be solely responsible. The Journal of Pharmacology and Experimental Therapeutics has retracted this article.

Contributor Information

Gary A. Wayman, Email: waymang@vetmed.wsu.edu.

Joseph W. Harding, Email: hardingj@vetmed.wsu.edu.


Articles from The Journal of Pharmacology and Experimental Therapeutics are provided here courtesy of American Society for Pharmacology and Experimental Therapeutics

RESOURCES